Tango Therapeutics Inc Share Price (NASDAQ: TNGX)

Tango Therapeutics Inc Stock Performance

as on October 14, 2025 at 1:29 am IST

Day's Low
Day's High
$7.25
Day's Price Range
$8.59
$8.47
14.40%
Downside
1.42%
Upside
52 Week's Low
52 Week's High
$1.03
52-Week Price Range
$8.8
$8.47
87.84%
Downside
3.90%
Upside

Tango Therapeutics Inc share price movements today

Previous Close: $7.14
Open: $7.38
Volume: 3.8M
Day's Low - High: $7.25 - $8.59
52 Week Low - High: $1.03 - $8.8

Tango Therapeutics Inc Historical Returns

1 Month Return: + 29.71 %
3 Month Return: + 39.08 %
1 Year Return: + 23.83 %
3 Year Return: + 63.83 %
5 Year Return: 0 %

Tango Therapeutics Inc Stock Fundamentals & Key Indicators

Check Tango Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$794.4M

EPS (TTM)

-1.0859

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-10.23

Industry PE ratio

PEG Ratio

EBITDA

-154.8M

Revenue (TTM)

24.3M

Profit Margin

0.00%

Return On Equity TTM

8353000.00%

Tango Therapeutics Inc Stock Valuation

Track how Tango Therapeutics Inc P/E has moved over time to understand its valuation trends.

Tango Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-28.97x)

September 30, 2021

Industry (0.00x)

October 14, 2025

Today (-10.23x)

October 14, 2025

Highest (-1.87x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -10.23x

Tango Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tango Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Tango Therapeutics Inc	BUY	$794.4M	NA	-10.23	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.3B	223.08%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.8B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$104.6B	50.07%	28.98	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.8B	-7.17%	14.23	31.37%

Stock Returns calculator for Tango Therapeutics Inc Stock including INR - Dollar returns

The Tango Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Tango Therapeutics Inc investment value today

Current value as on today

₹1,29,436

Returns

₹29,436

(+29.44%)

Returns from Tango Therapeutics Inc Stock

₹23,830 (+23.83%)

Dollar Returns*

₹5,606 (+5.61%)

Analyst Recommendation on Tango Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Tango Therapeutics Inc. Average target price of $10.88

Tango Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Tango Therapeutics Inc.

What analysts predicted

22.15%UPSIDE

Target Price

$10.88

Current Price

$8.47

Analyzed by

14 Analysts

Target

$10.88

Tango Therapeutics Inc target price $10.88, a slight upside of 22.15% compared to current price of $8.47. According to 14 analysts rating.

Tango Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Tango Therapeutics Inc Stock has increased by 175% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 14, 2025 to October 14, 2025

Change:175% versus previous 30 day period

Tango Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	5	14	10	5	6	19	11	4	5	3
Gross Profit	4	13	10	4	5	19	11	4	5	2
Operating Income	-30	-23	-25	-35	-42	-29	-32	-40	-42	-40
EBITDA	-29	-22	-25	-34	-41	-28	-32	-40	-41	-38
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-28	-20	-22	-30	-37	-25	-29	-37	-39	-38
Income Tax Expense	-2	0	0	0	0	0	0	0	0	0
Net Income	-25	-20	-22	-30	-37	-25	-29	-37	-39	-38
Net Profit Margin	-446.24%	-141.87%	-207.45%	-566.43%	-585.91%	-128.56%	-251.29%	-914.99%	-739.54%	-1221.41%

Tango Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	24	7	37	24	36	42
Gross Profit	-7	6	37	24	-78	42
Operating Income	-15	-52	-58	-111	-114	-145
EBITDA	-14	-51	-57	-109	-111	-143
Interest Expense	-	-	1	2	-	-
Depreciation	-	0	0	1	2	2
Income Before Tax	-14	-51	-57	-108	-101	-130
Income Tax Expense	-	0	0	0	0	0
Net Income	-14	-51	-58	-108	-101	-130
Net Profit Margin	-57.18%	-677.43%	-157.21%	-435.14%	-278.54%	-309.73%

Tango Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-20	-22	-30	-37	-25	-29	-37	-39	-38
Operating Cash Flow	-24	-31	-27	-37	-23	-33	-36	-41	-36
Investing Cash Flow	32	-56	33	-11	12	32	52	30	16
Financing Cash Flow	0	80	1	42	1	2	0	0	0
Change in Cash	8	-7	7	-6	-9	1	16	-11	-19

Tango Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-51	-58	-108	-101	-130
Operating Cash Flow	70	-59	-109	-117	-131
Investing Cash Flow	-145	-183	26	41	86
Financing Cash Flow	80	357	1	82	47
Change in Cash	5	114	-81	5	2

Global Institutional Holdings in Tango Therapeutics Inc

Funds	Holdings
TRV GP IV, LLC	15.15%
TCG Crossover Management, LLC	9.65%
EcoR1 Capital, LLC	9.55%
Boxer Capital Management, LLC	8.78%
Farallon Capital Management, L.L.C.	8.23%

See all

Insights on Tango Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -39.87M → -38.85M (in $), with an average increase of 2.6% per quarter
POSITIVE IMPACT
Price Rise
In the last 6 months, TNGX stock has moved up by 432.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 148.2% return, outperforming this stock by 110.1%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.5% return, outperforming this stock by 58.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 5.39M → 3.18M (in $), with an average decrease of 41.0% per quarter

About Tango Therapeutics Inc

tango therapeutics is a biotechnology company discovering and developing novel medicines targeting cancer vulnerabilities to deliver transformational new therapies for patients. tango was launched in 2017 with a $55 million series a investment from third rock ventures. the company has established a robust product engine that leverages advances in dna sequencing and crispr-based target discovery to generate breakthrough medicines that have the potential to provide deeper, more sustained benefit than today’s targeted therapies, and extend the benefit of available immuno-oncology agents. tango therapeutics is focused on three areas of drug development, each in well-defined patient populations currently lacking effective treatment options, and each with hallmarks of cancer that have not been targeted yet. these include: loss of tumor suppressor gene function; multiple oncogenic drivers; and immune evasion. what fuels each of tango’s programs is an increasingly sophisticated ability to util

Organisation	Tango Therapeutics Inc
Headquarters	201 Brookline Avenue, Boston, MA, United States, 02215
CEO	Dr. Barbara L. Weber M.D.
E-voting on shares	Click here to vote

Key Management of Tango Therapeutics Inc

Name	Title
Dr. Adam S. Crystal M.D., Ph.D.	President of Research & Development
Prof. Alan Ashworth FRS, Ph.D.	Founder & Member of Scientific Advisory Board
Dr. William G. Kaelin Jr., M.D.	Founder & Member of Scientific Advisory Board
Ms. Elizabeth Pingpank Hickin	VP of IR & Corporate Communications
Dr. Barbara L. Weber M.D.	President, CEO & Director
Ms. Daniella Beckman CPA	Chief Financial Officer
Mr. Douglas J. Barry Esq., J.D.	Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Dr. Antoni Ribas M.D., Ph.D.	Founder & Member of Scientific Advisory Board
Dr. Michael Palmieri Ph.D.	Chief Technical Operations Officer
Mr. Jannik N. Andersen Ph.D.	Chief Scientific Officer

FAQs

What is Tango Therapeutics Inc share price today?

Tango Therapeutics Inc share price today is $8.47 as on October 14, 2025 at 1:29 am IST at the close of the market. Tango Therapeutics Inc share today touched a day high of $8.59 and a low of $7.25.

What is the 52 week high and 52 week low for Tango Therapeutics Inc share?

Tango Therapeutics Inc share touched a 52 week high of $8.8 on September 29, 2025 and a 52 week low of $1.03 on May 8, 2025. Tango Therapeutics Inc stock price today i.e. October 14, 2025 at 1:29 am IST is closed at $8.47,which is 3.75% down from its 52 week high and 722.33% up from its 52 week low.

What is Tango Therapeutics Inc's market capitalisation today?

Tango Therapeutics Inc market capitalisation is $0.00T as on October 14, 2025 at 1:29 am IST.

How to invest in Tango Therapeutics Inc Stock (TNGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Tango Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tango Therapeutics Inc Shares that will get you 0.1771 shares as per Tango Therapeutics Inc share price of $8.47 per share as on October 14, 2025 at 1:29 am IST.

What is the minimum amount required to buy Tango Therapeutics Inc Stock (TNGX) from India?

Indian investors can start investing in Tango Therapeutics Inc (TNGX) shares with as little as ₹88.635 or $1 (as of October 14, 2025 at 11:54 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.35 in Tango Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 14, 2025 at 11:54 am IST). Based on Tango Therapeutics Inc share’s latest price of $8.47 as on October 14, 2025 at 1:29 am IST, you will get 1.1806 shares of Tango Therapeutics Inc. Learn more about fractional shares .